{
  "id": "map_1894",
  "title": "Enfermedad de Parkinson\\NDic 2024",
  "specialty": "Neurolog√≠a",
  "tag": "üìã Gu√≠a Cl√≠nica",
  "node_count": 870,
  "root": {
    "text": "Enfermedad de Parkinson\\NDic 2024",
    "children": [
      {
        "text": "Definici√≥n:",
        "children": [
          {
            "text": "‚Ä¢ Enfermedad\\Nneurodegenerativa progresiva.",
            "children": [
              {
                "text": "Progresi√≥n anat√≥mica definida (Braak)",
                "children": []
              },
              {
                "text": "Afectaci√≥n multisist√©mica progresiva",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä¢ Descrita en 1817 por James Parkinson (par√°lisis agitante).",
            "children": []
          },
          {
            "text": "‚Ä¢ Frederick Lewy (1912) identifica inclusiones presin√°pticas",
            "children": [
              {
                "text": "Inclusiones Œ±-sinucle√≠na (cuerpos Lewy)",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä¢ Causa: p√©rdida neuronal en la sustancia negra pars compacta\\N‚Üí d√©ficit de dopamina.",
            "children": [
              {
                "text": "Alteraci√≥n circuitos GB-t√°lamo-cortical",
                "children": []
              },
              {
                "text": "D√©ficit dopamin√©rgico estriatal",
                "children": []
              },
              {
                "text": "Disfunci√≥n neurotransmisores m√∫ltiples",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä¢ Trastorno con s√≠ntomas motores (rigidez, bradicinesia, temblor en reposo) y no motores.",
            "children": []
          }
        ]
      },
      {
        "text": "HISTORIA",
        "children": [
          {
            "text": "- James Parkinson\\N(1817)",
            "children": [
              {
                "text": "1. Publicaci√≥n\\Noriginal",
                "children": [
                  {
                    "text": "- \"Essay on Shaking Palsy\"",
                    "children": []
                  },
                  {
                    "text": "- Primera descripci√≥n sistem√°tica",
                    "children": []
                  },
                  {
                    "text": "- Seis casos cl√≠nicos detallados",
                    "children": []
                  }
                ]
              },
              {
                "text": "2. Caracter√≠sticas\\Ndescritas",
                "children": [
                  {
                    "text": "- \"Movimientos tr√©mulos involuntarios\"",
                    "children": []
                  },
                  {
                    "text": "- Disminuci√≥n fuerza muscular",
                    "children": []
                  },
                  {
                    "text": "- Tendencia a inclinaci√≥n tronco",
                    "children": []
                  },
                  {
                    "text": "- Marcha festinante",
                    "children": []
                  },
                  {
                    "text": "- Preservaci√≥n \"sentidos e intelecto\"",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "- Jean-Martin Charcot\\N(1872)",
            "children": [
              {
                "text": "1. Aportes\\Nfundamentales",
                "children": [
                  {
                    "text": "- T√©rmino \"Enfermedad de Parkinson\"",
                    "children": []
                  },
                  {
                    "text": "- Diferenciaci√≥n temblor reposo/acci√≥n",
                    "children": []
                  },
                  {
                    "text": "- Descripci√≥n rigidez",
                    "children": []
                  },
                  {
                    "text": "- Distinci√≥n esclerosis m√∫ltiple",
                    "children": []
                  }
                ]
              },
              {
                "text": "2. Primeros\\Ntratamientos",
                "children": [
                  {
                    "text": "- Alcaloides belladona",
                    "children": []
                  },
                  {
                    "text": "- Sales met√°licas",
                    "children": []
                  },
                  {
                    "text": "- Ergotam√≠nicos",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "1. Fritz Lewy\\N(1912)",
            "children": [
              {
                "text": "- Descripci√≥n cuerpos inclusi√≥n",
                "children": []
              },
              {
                "text": "- Afectaci√≥n sustancia nigra",
                "children": []
              },
              {
                "text": "- Base patol√≥gica neuronal",
                "children": []
              }
            ]
          },
          {
            "text": "2. Tretiakoff\\N(1919)",
            "children": [
              {
                "text": "- Correlaci√≥n cl√≠nico-patol√≥gica",
                "children": []
              },
              {
                "text": "- P√©rdida neuronal SNpc",
                "children": []
              },
              {
                "text": "- Degeneraci√≥n sistem√°tica",
                "children": []
              }
            ]
          },
          {
            "text": "1. Carlsson\\N(1957)",
            "children": [
              {
                "text": "- Identificaci√≥n dopamina",
                "children": []
              },
              {
                "text": "- Rol neurotransmisor",
                "children": []
              },
              {
                "text": "- Base tratamiento actual",
                "children": []
              }
            ]
          },
          {
            "text": "2. Cotzias\\N(1967)",
            "children": [
              {
                "text": "- Introducci√≥n L-DOPA oral",
                "children": []
              },
              {
                "text": "- Tratamiento efectivo",
                "children": []
              },
              {
                "text": "- Revoluci√≥n terap√©utica",
                "children": []
              }
            ]
          },
          {
            "text": "1. Braak (2003)",
            "children": [
              {
                "text": "- Estadificaci√≥n patol√≥gica",
                "children": []
              },
              {
                "text": "- Progresi√≥n sistem√°tica",
                "children": []
              },
              {
                "text": "- Base comprensi√≥n actual",
                "children": []
              }
            ]
          },
          {
            "text": "2. Bases\\Nmoleculares",
            "children": [
              {
                "text": "- Œ±-sinucle√≠na (1997)",
                "children": []
              },
              {
                "text": "- Genes PARK",
                "children": []
              },
              {
                "text": "- Mecanismos neurodegeneraci√≥n",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "EPIDEMIOLOG√çA",
        "children": [
          {
            "text": "‚Ä¢ Pr√≥dromo prolongado: Hasta 10 a√±os antes con s√≠ntomas no motores.",
            "children": []
          },
          {
            "text": "‚Ä¢ Prevalencia: ~2% de la poblaci√≥n mayor de 65 a√±os.",
            "children": []
          },
          {
            "text": "‚Ä¢ Edad promedio de diagn√≥stico: 70 a√±os.",
            "children": [
              {
                "text": "Aumenta con la edad",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä¢ H:M = 3:2",
            "children": []
          },
          {
            "text": "‚Ä¢ Incidencia: 14/100. 000 personas-a√±o",
            "children": []
          },
          {
            "text": "‚Ä¢ 25% con antecedentes familiares.",
            "children": []
          },
          {
            "text": "‚Ä¢ Cobertura GES desde 2010",
            "children": []
          }
        ]
      },
      {
        "text": "FACTORES\\NDE RIESGO",
        "children": [
          {
            "text": "AMBIENTALES",
            "children": [
              {
                "text": "- Riesgo aumentado\\N(OR>1)",
                "children": [
                  {
                    "text": "1. Exposici√≥n\\Nocupacional",
                    "children": [
                      {
                        "text": "- Pesticidas/agroqu√≠micos",
                        "children": []
                      },
                      {
                        "text": "- Trabajo agr√≠cola",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Vivir en zonas rurales.",
                        "children": [
                          {
                            "text": "- Agua pozo rural",
                            "children": []
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "text": "2. Trauma",
                    "children": [
                      {
                        "text": "- Lesi√≥n craneal previa",
                        "children": []
                      },
                      {
                        "text": "- TCE moderado-severo",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "3. F√°rmacos",
                    "children": [
                      {
                        "text": "- Beta-bloqueadores",
                        "children": []
                      },
                      {
                        "text": "- Calcio antagonistas",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "- Riesgo disminuido\\N(OR<1)",
                "children": [
                  {
                    "text": "1. H√°bitos",
                    "children": [
                      {
                        "text": "- Tabaquismo",
                        "children": []
                      },
                      {
                        "text": "- Consumo caf√©",
                        "children": []
                      },
                      {
                        "text": "- Alcohol moderado",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "2. Medicamentos",
                    "children": [
                      {
                        "text": "- AINE cr√≥nico",
                        "children": []
                      },
                      {
                        "text": "- BCC prolongado",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "GEN√âTICOS",
            "children": [
              {
                "text": "- Riesgo aumentado (OR>1)",
                "children": [
                  {
                    "text": "‚Ä¢ Mutaciones en genes como GBA, LRRK2, SNCA, VPS13C.",
                    "children": []
                  }
                ]
              },
              {
                "text": "- Riesgo disminuido (OR<1)",
                "children": [
                  {
                    "text": "‚Ä¢ Mutaciones en MAPT, TMEM175, HLA-DQB1.",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "Los factores gen√©ticos y ambientales interact√∫an para determinar susceptibilidad a la enfermedad.",
            "children": []
          }
        ]
      },
      {
        "text": "FISIOPATOLOG√çA",
        "children": [
          {
            "text": "",
            "children": [
              {
                "text": "1. Depleci√≥n de c√©lulas\\Ndopamin√©rgicas:",
                "children": [
                  {
                    "text": "‚Ä¢ Ubicaci√≥n: Sustancia negra, v√≠a nigroestriatal (caudado y putamen).",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Efectos:",
                    "children": [
                      {
                        "text": "‚Ä¢ ‚Üë Inhibici√≥n del t√°lamo.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ ‚Üì Input excitatorio hacia la corteza motora.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Resultado: Bradicinesia y rigidez.",
                    "children": []
                  }
                ]
              },
              {
                "text": "2. Alteraciones celulares\\N(interacci√≥n gen√©tico-ambiental):",
                "children": [
                  {
                    "text": "‚Ä¢ Agregaci√≥n\\Nde prote√≠nas:",
                    "children": [
                      {
                        "text": "‚Ä¢ Alfa-sinucle√≠na (cuerpos de Lewy).",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Tau (disfunci√≥n estructural).",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Sistema\\Nubiquitina-proteosoma:",
                    "children": [
                      {
                        "text": "‚Ä¢ Alteraci√≥n del tr√°fico y degradaci√≥n de prote√≠nas intracelulares.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Alteraciones en prote√≠nas de membrana.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Disfunci√≥n\\Nmitocondrial:",
                    "children": [
                      {
                        "text": "‚Ä¢ Aumento del estr√©s oxidativo.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Disfunci√≥n lisosomal.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Alteraci√≥n sin√°ptica y neurotransmisi√≥n dopamin√©rgica.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Transmisi√≥n pri√≥nica:",
                    "children": [
                      {
                        "text": "‚Ä¢ Propagaci√≥n de alfa-sinucle√≠na a trav√©s de sinapsis.",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "‚ö†Ô∏è",
                "children": [
                  {
                    "text": "‚Ä¢ Formaci√≥n de cuerpos de Lewy.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Disfunci√≥n mitocondrial y lisosomal.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Alteraciones en tr√°fico sin√°ptico.",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "",
            "children": [
              {
                "text": "1. Factores\\Ninvolucrados:",
                "children": [
                  {
                    "text": "‚Ä¢ Ambientales y\\Nestilo de vida:",
                    "children": [
                      {
                        "text": "‚Ä¢ Exposici√≥n a pesticidas, metales pesados (Mn, Fe).",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Factores diet√©ticos y t√≥xicos.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Gen√©ticos:",
                    "children": [
                      {
                        "text": "‚Ä¢ Mutaciones asociadas con prote√≠nas como alfa-sinucle√≠na, LRRK2, Parkin, etc.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Envejecimiento:",
                    "children": [
                      {
                        "text": "‚Ä¢ ‚Üë Estr√©s oxidativo y acumulaci√≥n de da√±o celular.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Factores desconocidos:",
                    "children": [
                      {
                        "text": "‚Ä¢ Pueden influir en la progresi√≥n y manifestaci√≥n individual.",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "2. Mecanismos\\Ncelulares:",
                "children": [
                  {
                    "text": "‚Ä¢ Estr√©s oxidativo:",
                    "children": [
                      {
                        "text": "‚Ä¢ Generaci√≥n de especies reactivas de ox√≠geno (ROS) ‚Üí da√±o mitocondrial.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Disfunci√≥n en la\\Neliminaci√≥n de prote√≠nas:",
                    "children": [
                      {
                        "text": "‚Ä¢ Alteraciones en el sistema ubiquitina-proteasoma y autofagia-lisosoma.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Acumulaci√≥n de alfa-sinucle√≠na mal plegada y agregada.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Disfunci√≥n mitocondrial:",
                    "children": [
                      {
                        "text": "‚Ä¢ ‚Üì Producci√≥n de energ√≠a ‚Üí muerte neuronal.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Neuroinflamaci√≥n:",
                    "children": [
                      {
                        "text": "‚Ä¢ Activaci√≥n microglial cr√≥nica ‚Üí liberaci√≥n de citoquinas proinflamatorias.",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "3. Impacto\\Nneuroanat√≥mico:",
                "children": [
                  {
                    "text": "‚Ä¢ Afectaci√≥n inicial en el tronco encef√°lico (sistema nervioso aut√≥nomo).",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Progresi√≥n hacia los ganglios basales (sustancia negra) y corteza cerebral.",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "MECANISMOS\\NPATOL√ìGICOS PRIMARIOS",
            "children": [
              {
                "text": "A. Alteraci√≥n\\NProteica",
                "children": [
                  {
                    "text": "- Agregaci√≥n patol√≥gica Œ±-sinucle√≠na",
                    "children": []
                  },
                  {
                    "text": "- Disfunci√≥n sistema ubiquitina-proteosoma",
                    "children": []
                  },
                  {
                    "text": "- Alteraci√≥n autofagia celular",
                    "children": []
                  },
                  {
                    "text": "- Propagaci√≥n tipo pri√≥n",
                    "children": []
                  }
                ]
              },
              {
                "text": "B. Disfunci√≥n\\NMitocondrial",
                "children": [
                  {
                    "text": "- Estr√©s oxidativo aumentado",
                    "children": []
                  },
                  {
                    "text": "- Alteraci√≥n cadena respiratoria",
                    "children": []
                  },
                  {
                    "text": "- Disfunci√≥n complejo I mitocondrial",
                    "children": []
                  },
                  {
                    "text": "- Acumulaci√≥n ROS",
                    "children": []
                  }
                ]
              },
              {
                "text": "C. Neuroinflamaci√≥n",
                "children": [
                  {
                    "text": "- Activaci√≥n microglial cr√≥nica",
                    "children": []
                  },
                  {
                    "text": "- Liberaci√≥n citoquinas proinflamatorias",
                    "children": []
                  },
                  {
                    "text": "- Alteraci√≥n barrera hematoencef√°lica",
                    "children": []
                  },
                  {
                    "text": "- Infiltraci√≥n c√©lulas inmunes",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "VULNERABILIDAD\\NNEURONAL SELECTIVA",
            "children": [
              {
                "text": "A. Sistema\\NDopamin√©rgico",
                "children": [
                  {
                    "text": "- SNpc: p√©rdida neuronal progresiva",
                    "children": []
                  },
                  {
                    "text": "- D√©ficit dopamina estriatal",
                    "children": []
                  },
                  {
                    "text": "- Alteraci√≥n v√≠as directa/indirecta",
                    "children": []
                  },
                  {
                    "text": "- Desequilibrio neurotransmisor",
                    "children": []
                  }
                ]
              },
              {
                "text": "B. Sistemas\\NNo-Dopamin√©rgicos",
                "children": [
                  {
                    "text": "- Noradren√©rgico: LC (atenci√≥n/alerta)",
                    "children": []
                  },
                  {
                    "text": "- Serotonin√©rgico: NR (humor/sue√±o)",
                    "children": []
                  },
                  {
                    "text": "- Colin√©rgico: NBM (cognici√≥n)",
                    "children": []
                  },
                  {
                    "text": "- Glutamat√©rgico: corteza motora",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "CONSECUENCIAS\\NFUNCIONALES",
            "children": [
              {
                "text": "A. Circuitos\\NMotores",
                "children": [
                  {
                    "text": "- Inhibici√≥n tal√°mica aumentada",
                    "children": []
                  },
                  {
                    "text": "- Reducci√≥n output motor cortical",
                    "children": []
                  },
                  {
                    "text": "- Alteraci√≥n control movimiento fino",
                    "children": []
                  },
                  {
                    "text": "- D√©ficit ajuste postural",
                    "children": []
                  }
                ]
              },
              {
                "text": "B. Circuitos\\NNo-Motores",
                "children": [
                  {
                    "text": "- Disfunci√≥n frontoestriatal",
                    "children": []
                  },
                  {
                    "text": "- Alteraci√≥n sistema l√≠mbico",
                    "children": []
                  },
                  {
                    "text": "- Compromiso sistema auton√≥mico",
                    "children": []
                  },
                  {
                    "text": "- Desregulaci√≥n ciclo sue√±o-vigilia",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "CONSIDERACIONES\\NGERI√ÅTRICAS",
            "children": [
              {
                "text": "A. Factores\\NAgravantes",
                "children": [
                  {
                    "text": "- Envejecimiento celular acelerado",
                    "children": []
                  },
                  {
                    "text": "- Comorbilidades vasculares",
                    "children": []
                  },
                  {
                    "text": "- Polifarmacia frecuente",
                    "children": []
                  },
                  {
                    "text": "- Reserva funcional disminuida",
                    "children": []
                  }
                ]
              },
              {
                "text": "B. Impacto Sistema\\NSanitario Chile",
                "children": [
                  {
                    "text": "- Consulta tard√≠a promedio",
                    "children": []
                  },
                  {
                    "text": "- Acceso limitado especialistas",
                    "children": []
                  },
                  {
                    "text": "- Variabilidad manejo territorial",
                    "children": []
                  },
                  {
                    "text": "- Recursos rehabilitaci√≥n desiguales",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "DIAGN√ìSTICO",
        "children": [
          {
            "text": "S√≠ndrome\\Nparkinsoniano:",
            "children": [
              {
                "text": "‚Ä¢ Bradicinesia m√°s uno o\\Nm√°s de los siguientes:",
                "children": [
                  {
                    "text": "‚Ä¢ Rigidez muscular.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Temblor en reposo (4-6 Hz).",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Inestabilidad postural no causada por disfunci√≥n vestibular, cerebelosa o visual.",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "Criterios actuales de la Movement\\NDisorders Society (MDS):",
            "children": [
              {
                "text": "‚Ä¢ Criterio esencial:",
                "children": [
                  {
                    "text": "‚Ä¢ Bradicinesia en combinaci√≥n con al\\Nmenos uno de los siguientes:",
                    "children": [
                      {
                        "text": "‚Ä¢ Temblor en reposo.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Rigidez muscular.",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "‚Ä¢ Diagn√≥stico definitivo:",
                "children": [
                  {
                    "text": "‚Ä¢ Ausencia de criterios absolutos de exclusi√≥n.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Presencia de al menos 2 criterios de apoyo.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ No m√°s de 2 ‚Äúred flags‚Äù (banderas rojas).",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Diagn√≥stico probable:",
                "children": [
                  {
                    "text": "‚Ä¢ Sin criterios absolutos de exclusi√≥n.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Si hay una ‚Äúred flag‚Äù, debe estar compensada con un criterio de apoyo.",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "Proceso de Diagn√≥stico\\NEnfoque en 4 pasos",
        "children": [
          {
            "text": "Paso 1: \\NIdentificar parkinsonismo.",
            "children": [
              {
                "text": "‚Ä¢ Presencia de bradicinesia m√°s\\Nuno de los siguientes:",
                "children": [
                  {
                    "text": "‚Ä¢ Temblor en reposo.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Rigidez muscular.",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "Paso 2\\NIdentificar criterios de apoyo.",
            "children": [
              {
                "text": "‚Ä¢ Respuesta inequ√≠voca\\Ny dram√°tica a levodopa.",
                "children": [
                  {
                    "text": "‚Ä¢ Retorno a la funci√≥n normal o casi normal durante el tratamiento inicial.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Documentar cambios objetivos en la escala UPDRS III (>30%) o\\Ncambios subjetivos marcados reportados por el paciente/cuidador.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Presencia de disquinesias inducidas por levodopa.",
                "children": []
              },
              {
                "text": "‚Ä¢ Temblor en reposo documentado:",
                "children": [
                  {
                    "text": "‚Ä¢ Evidente cl√≠nicamente, ya sea pasado o actual.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ P√©rdida del olfato o denervaci√≥n simp√°tica card√≠aca:",
                "children": [
                  {
                    "text": "‚Ä¢ Documentado mediante gammagraf√≠a MIBG.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Otros s√≠ntomas motores o no motores que apoyen el diagn√≥stico.",
                "children": []
              }
            ]
          },
          {
            "text": "Paso 3: \\NExcluir criterios absolutos de exclusi√≥n.",
            "children": [
              {
                "text": "‚Ä¢ Signos\\Ncerebelosos.",
                "children": [
                  {
                    "text": "- Ataxia cerebelosa",
                    "children": []
                  },
                  {
                    "text": "- Nistagmo downbeat",
                    "children": []
                  },
                  {
                    "text": "- Dismetr√≠a severa",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Supranucleares",
                "children": [
                  {
                    "text": "- Oftalmoplej√≠a vertical",
                    "children": []
                  },
                  {
                    "text": "- Par√°lisis supranuclear",
                    "children": [
                      {
                        "text": "‚Ä¢ P√©rdida sensorial cortical (agrafestesia, astereognosia).",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "- Sacadas lentas",
                    "children": [
                      {
                        "text": "‚Ä¢ O movimientos sac√°dicos descendentes selectivamente lentos.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "- Alteraciones corticales sensoriales inequ√≠vocas:",
                    "children": [
                      {
                        "text": "‚Ä¢ Apraxia ideomotora clara o afasia progresiva.",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "‚Ä¢ Otros\\Nparkinsonismos",
                "children": [
                  {
                    "text": "- Vascular establecido",
                    "children": []
                  },
                  {
                    "text": "- Hidrocefalia documentada",
                    "children": []
                  },
                  {
                    "text": "- Lesiones estructurales",
                    "children": []
                  },
                  {
                    "text": "- Parkinsonismo restringido a extremidades inferiores:",
                    "children": [
                      {
                        "text": "‚Ä¢ Sin progresi√≥n por m√°s de 3 a√±os.",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "‚Ä¢ Ausencia de respuesta observable a levodopa:",
                "children": [
                  {
                    "text": "- A pesar de dosis altas y severidad moderada de la enfermedad.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Tratamiento reciente con bloqueadores del receptor dopamin√©rgico.",
                "children": []
              },
              {
                "text": "‚Ä¢ Tratamiento con bloqueadores de dopamina:",
                "children": [
                  {
                    "text": "- O agentes que disminuyan dopamina, en dosis y duraci√≥n consistentes con parkinsonismo inducido por f√°rmacos.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Diagn√≥stico confirmado de otras enfermedades neurodegenerativas:",
                "children": [
                  {
                    "text": "- Variante conductual de demencia frontotemporal o afasia progresiva primaria dentro de los 5 a√±os.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Evidencia de otra condici√≥n alternativa:",
                "children": [
                  {
                    "text": "- Causa m√°s probable de los s√≠ntomas seg√∫n evaluaci√≥n cl√≠nica completa.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Imagen funcional presin√°ptica de dopamina normal.",
                "children": []
              }
            ]
          },
          {
            "text": "Paso 4: \\NBuscar banderas rojas",
            "children": [
              {
                "text": "‚Ä¢ Progresi√≥n r√°pida",
                "children": [
                  {
                    "text": "- Silla ruedas <5 a√±os",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Ca√≠das frecuentes inicio",
                "children": [
                  {
                    "text": "‚Ä¢ Disautonom√≠a severa precoz.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Disfunci√≥n\\Nbulbar temprana:",
                "children": [
                  {
                    "text": "‚Ä¢ Disfagia severa o disartria significativa dentro de los primeros 5 a√±os.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Requiere alimentaci√≥n por sonda o gastrostom√≠a.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Falla auton√≥mica severa en\\Nlos primeros 5 a√±os:",
                "children": [
                  {
                    "text": "‚Ä¢ Hipotensi√≥n ortost√°tica severa o retenci√≥n urinaria grave.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Incontinencia urinaria no atribuible a enfermedad prost√°tica en hombres.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Parkinsonismo bilateral y sim√©trico:",
                "children": [
                  {
                    "text": "‚Ä¢ Sin predominio lateral, evidente en el examen objetivo.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Ausencia de caracter√≠sticas no motoras t√≠picas:",
                "children": [
                  {
                    "text": "‚Ä¢ Trastornos del sue√±o REM, hiposmia, constipaci√≥n, disfunci√≥n auton√≥mica, depresi√≥n, ansiedad, alucinaciones.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Disfunci√≥n respiratoria:",
                "children": [
                  {
                    "text": "‚Ä¢ Estridor inspiratorio o suspiros frecuentes diurnos o nocturnos.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Ausencia de progresi√≥n motora durante m√°s de 5 a√±os:",
                "children": [
                  {
                    "text": "‚Ä¢ Excluye casos relacionados con tratamiento.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Ca√≠das recurrentes (m√°s de una por a√±o):",
                "children": [
                  {
                    "text": "‚Ä¢ Dentro de los primeros 3 a√±os, causadas por p√©rdida de equilibrio.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Postura desproporcionada:",
                "children": [
                  {
                    "text": "‚Ä¢ Anterocolis (diston√≠a) o contracturas de manos y pies dentro de los primeros 10 a√±os.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Signos piramidales inexplicables:",
                "children": [
                  {
                    "text": "‚Ä¢ Debilidad piramidal o hiperreflexia patol√≥gica clara (excluyendo hiperreflexia leve).",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Ausencia\\Ncaracter√≠sticas t√≠picas",
                "children": [
                  {
                    "text": "- No asimetr√≠a persistente",
                    "children": [
                      {
                        "text": "‚Ä¢ Parkinsonismo bilateral y sim√©trico.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "- No beneficio L-DOPA",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "Cl√≠nica",
        "children": [
          {
            "text": "La combinaci√≥n de s√≠ntomas motores y no motores var√≠a entre pacientes, pero los\\Nno motores son a menudo responsables de mayor impacto en la calidad de vida.",
            "children": []
          },
          {
            "text": "S√≠ntomas\\NMotores:",
            "children": [
              {
                "text": "1. Temblor:",
                "children": [
                  {
                    "text": "‚Ä¢ Predominantemente en reposo.",
                    "children": []
                  }
                ]
              },
              {
                "text": "2. Rigidez muscular:",
                "children": [
                  {
                    "text": "‚Ä¢ Incremento del tono muscular.",
                    "children": []
                  }
                ]
              },
              {
                "text": "3. Bradicinesia/Aquinesia/Hipocinesia:",
                "children": [
                  {
                    "text": "‚Ä¢ Movimientos lentos o dificultad para iniciarlos.",
                    "children": []
                  }
                ]
              },
              {
                "text": "4. Inestabilidad postural:",
                "children": [
                  {
                    "text": "‚Ä¢ Predispone a ca√≠das.",
                    "children": []
                  }
                ]
              },
              {
                "text": "5. Anormalidades posturales:",
                "children": [
                  {
                    "text": "‚Ä¢ Ejemplo: camptocormia, s√≠ndrome de Pisa.",
                    "children": []
                  }
                ]
              },
              {
                "text": "6. Trastornos de\\Nla marcha:",
                "children": [
                  {
                    "text": "‚Ä¢ Freezing (bloqueo de la marcha).",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Festinaci√≥n (pasos peque√±os y r√°pidos).",
                    "children": []
                  }
                ]
              },
              {
                "text": "7. Alteraciones en el parpadeo y movimientos oculares.",
                "children": []
              },
              {
                "text": "8. Hipomimia:",
                "children": [
                  {
                    "text": "‚Ä¢ Disminuci√≥n de la expresi√≥n facial.",
                    "children": []
                  }
                ]
              },
              {
                "text": "9. Micrograf√≠a:",
                "children": [
                  {
                    "text": "‚Ä¢ Escritura progresivamente m√°s peque√±a.",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "S√≠ntomas No\\NMotores:",
            "children": [
              {
                "text": "1. Ps√≠quicos:",
                "children": [
                  {
                    "text": "‚Ä¢ Depresi√≥n, ansiedad, apat√≠a.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Alucinaciones, psicosis.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Deterioro cognitivo/demencia.",
                    "children": []
                  }
                ]
              },
              {
                "text": "2. Sensoriales:",
                "children": [
                  {
                    "text": "‚Ä¢ Hiposmia (p√©rdida del olfato).",
                    "children": []
                  }
                ]
              },
              {
                "text": "3. Genitourinarios:",
                "children": [
                  {
                    "text": "‚Ä¢ Urgencia urinaria, frecuencia, disfunci√≥n sexual.",
                    "children": []
                  }
                ]
              },
              {
                "text": "4. Gastrointestinales:",
                "children": [
                  {
                    "text": "‚Ä¢ Disfagia, sialorrea.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Estre√±imiento, vaciamiento g√°strico retardado.",
                    "children": []
                  }
                ]
              },
              {
                "text": "5. Trastornos del sue√±o:",
                "children": [
                  {
                    "text": "‚Ä¢ Insomnio, trastornos del sue√±o REM.",
                    "children": []
                  }
                ]
              },
              {
                "text": "6. Cardiovasculares:",
                "children": [
                  {
                    "text": "‚Ä¢ Hipotensi√≥n postural, disritmias.",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "Cl√≠nica\\NDynaMedex ",
        "children": [
          {
            "text": "Historia ",
            "children": [
              {
                "text": "‚Üí S/S motores principales en EP\\N(Enf. Parkinson):",
                "children": [
                  {
                    "text": "- Temblor en reposo",
                    "children": []
                  },
                  {
                    "text": "- Bradicinesia (‚Üì velocidad movs.)",
                    "children": []
                  },
                  {
                    "text": "- Rigidez (‚Üë tono, pcte puede referir ‚Äúdificultad al girar en cama/salir de autos‚Äù)",
                    "children": []
                  },
                  {
                    "text": "- Micrograf√≠a (cambio en la escritura)",
                    "children": []
                  },
                  {
                    "text": "- Inestabilidad postural (pasos peque√±os, arrastre, ‚Üì braceo, dificultad al iniciar la marcha)",
                    "children": []
                  },
                  {
                    "text": "- ‚Üì destreza manual",
                    "children": []
                  },
                  {
                    "text": "- Dificultad en AVD (vestirse, levantarse de sillas/autos)",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Üí S/S no\\Nmotores:",
                "children": [
                  {
                    "text": "- Trastornos del sue√±o",
                    "children": []
                  },
                  {
                    "text": "- Deterioro cognitivo",
                    "children": []
                  },
                  {
                    "text": "- Alteraci√≥n del estado de √°nimo (depresi√≥n, ansiedad)",
                    "children": []
                  },
                  {
                    "text": "- Disautonom√≠a (hipotensi√≥n ortost√°tica, constipaci√≥n, s√≠ntomas urinarios)",
                    "children": []
                  },
                  {
                    "text": "- Dolor",
                    "children": []
                  },
                  {
                    "text": "- Hiposmia",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Üí HPI (Historia de la\\NEnfermedad Actual):",
                "children": [
                  {
                    "text": "- Preguntar por temblor en reposo (usualmente MMSS, tambi√©n ment√≥n, mand√≠bula, piernas).",
                    "children": []
                  },
                  {
                    "text": "- Puede reemerger tras deambulaci√≥n o con brazos extendidos luego de segundos.",
                    "children": []
                  },
                  {
                    "text": "- Ausencia de temblor en reposo NO excluye EP.",
                    "children": []
                  },
                  {
                    "text": "- Considerar temblor postural, de acci√≥n o mixto (Neurology 2018;90(13):e1095).",
                    "children": []
                  },
                  {
                    "text": "- Indagar lentitud, rigidez, cambios en marcha, voz suave, ‚Üì expresi√≥n facial, micrograf√≠a.",
                    "children": []
                  },
                  {
                    "text": "- Inicio insidioso, afecta 1 extremidad y se disemina a otras (asimetr√≠a suele persistir).",
                    "children": []
                  },
                  {
                    "text": "- No motores: hiposmia, trastornos del sue√±o, alteraciones cognitivas, depresi√≥n/ansiedad/apat√≠a, s√≠ntomas auton√≥micos\\N(constipaci√≥n, hipotensi√≥n ortost√°tica, fluctuaciones PA, urgencia urinaria), sialorrea, disfagia, dolor, fatiga.",
                    "children": []
                  },
                  {
                    "text": "- ‚ÄúRed flags‚Äù (posible parkinsonismo at√≠pico): progreso r√°pido de alteraciones en la marcha, ca√≠das tempranas,\\Ndisfunci√≥n respiratoria en el habla, disautonom√≠a severa temprana, deterioro cognitivo severo temprano.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Üí PMH (Antecedentes\\Npersonales):",
                "children": [
                  {
                    "text": "- Indagar inicio de s√≠ntomas no motores\\N(a veces presentes en fase prodr√≥mica).",
                    "children": []
                  },
                  {
                    "text": "- REM sleep behavior disorder e hiposmia pueden preceder los s√≠ntomas motores.",
                    "children": []
                  },
                  {
                    "text": "- Periodo prodr√≥mico puede iniciar incluso a los 20 a√±os.",
                    "children": []
                  },
                  {
                    "text": "- + s√≠ntomas prodr√≥micos ‚áí + riesgo de parkinsonismo.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Üí Medicamentos:",
                "children": [
                  {
                    "text": "- Ver respuesta previa o actual a levodopa (si NO hay respuesta adecuada, considerar parkinsonismo at√≠pico).",
                    "children": []
                  },
                  {
                    "text": "- Buscar f√°rmacos bloqueadores dopamin√©rgicos (p. ej. antipsic√≥ticos) como causa secundaria.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Üí Historia Familiar:",
                "children": [
                  {
                    "text": "- Indagar parientes de 1er grado con EP (‚Üë probabilidad de Dx).",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Üí SH (Historia Social):",
                "children": [
                  {
                    "text": "- Consum. de cafe√≠na, tabaco, alcohol.",
                    "children": []
                  },
                  {
                    "text": "- Sustancias controladas (MPTP -su metabolito MPT t√≥xico en ganglios basales-, mefedrona).",
                    "children": []
                  },
                  {
                    "text": "- Hierbas (kava, ra√≠z de serpiente india).",
                    "children": []
                  },
                  {
                    "text": "- Exposici√≥n a pesticidas, solventes, etc. (factores de riesgo EP).",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "‚Ä¢ Examen F√≠sico",
            "children": [
              {
                "text": "‚Üí General:",
                "children": [
                  {
                    "text": "- Bradicinesia, hipomimia (‚Üì expresividad facial), habla alterada (baja intensidad, mon√≥tona).",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Üí Piel:",
                "children": [
                  {
                    "text": "- Dermatitis seborreica facial posible.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Üí HEENT:",
                "children": [
                  {
                    "text": "- ‚Üì parpadeo (mirada fija).",
                    "children": []
                  },
                  {
                    "text": "- ‚Üì expresi√≥n facial.",
                    "children": []
                  },
                  {
                    "text": "- Evaluar hiposmia.",
                    "children": []
                  },
                  {
                    "text": "- Movs. oculares an√≥malos: saccadas lentas, persecuci√≥n discontinua, limitaci√≥n mirada vertical\\N(PSP), nistagmo evocado por la mirada (MSA) (J Mov Disord 2019;12(1):1).",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Üí Neuro:",
                "children": [
                  {
                    "text": "- Bradicinesia:",
                    "children": [
                      {
                        "text": "‚Ä¢ Movs. m√°s lentos/peque√±os en tareas repetitivas (tapping dedos/pies).",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Cara r√≠gida/hipom√≠mica.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Voz lenta o sin variaciones.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "- Temblor en reposo\\N(4-6 Hz, ‚Äúcontar\\Np√≠ldoras‚Äù):",
                    "children": [
                      {
                        "text": "‚Ä¢ Distal, r√≠tmico, m√°s en brazos (a veces piernas en <40 a√±os).",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Disminuye al mover, empeora con estr√©s.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Posible en mand√≠bula, ment√≥n, labios, lengua (>70 a√±os).",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Temblor reemergente: desaparece al extender extremidad y reaparece tras segundos.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "- Rigidez muscular (resistencia uniforme al mov. pasivo, con/ sin ‚Äúengranaje‚Äù).",
                    "children": []
                  },
                  {
                    "text": "- Inestabilidad postural y\\Nalteraciones de la marcha:",
                    "children": [
                      {
                        "text": "‚Ä¢ Freezing (dificultad para iniciar)",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Postura encorvada (tronco/MMSS)",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Ca√≠das hacia delante/lateral, giro ‚Äúen bloque‚Äù",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Pasos cortos con arrastre",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ ‚Üì braceo, un brazo flexionado",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "- Escritura:",
                    "children": [
                      {
                        "text": "‚Ä¢ Temblor t√≠picamente desaparece durante la escritura.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Letra peque√±a (micrograf√≠a).",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "- Diston√≠as (cervical, camptocormia, Pisa, pie).",
                    "children": []
                  },
                  {
                    "text": "- Usar UPDRS-3 para cuantificar signos motores y respuesta al tto.",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "Frecuencia de\\Nlos S√≠ntomas",
        "children": [
          {
            "text": "S√≠ntomas Motores\\NPrimarios:",
            "children": [
              {
                "text": "1. Temblor en reposo:",
                "children": [
                  {
                    "text": "‚Ä¢ Frecuencia: ~70% al diagn√≥stico.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Ocurre t√≠picamente en las etapas iniciales.",
                    "children": []
                  }
                ]
              },
              {
                "text": "2. Bradicinesia:",
                "children": [
                  {
                    "text": "‚Ä¢ Presente en todos los casos al diagn√≥stico o m√°s tarde.",
                    "children": []
                  }
                ]
              },
              {
                "text": "3. Rigidez:",
                "children": [
                  {
                    "text": "‚Ä¢ Frecuencia: ~90%.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Aparece al diagn√≥stico o posteriormente.",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "S√≠ntomas No Motores Tempranos\\N(pueden preceder al diagn√≥stico):",
            "children": [
              {
                "text": "1. Hiposmia:",
                "children": [
                  {
                    "text": "‚Ä¢ Frecuencia: 25-97%.",
                    "children": []
                  }
                ]
              },
              {
                "text": "2. Fatiga:",
                "children": [
                  {
                    "text": "‚Ä¢ Frecuencia: 60%.",
                    "children": []
                  }
                ]
              },
              {
                "text": "3. Depresi√≥n:",
                "children": [
                  {
                    "text": "‚Ä¢ Frecuencia: 25%.",
                    "children": []
                  }
                ]
              },
              {
                "text": "4. Trastornos del\\Nsue√±o REM",
                "children": [
                  {
                    "text": "‚Ä¢ Frecuencia: 50%.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Puede preceder al diagn√≥stico por 15 a√±os o m√°s.",
                    "children": []
                  }
                ]
              },
              {
                "text": "5. Constipaci√≥n:",
                "children": [
                  {
                    "text": "‚Ä¢ Frecuencia: 30%.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Puede preceder al diagn√≥stico.",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "S√≠ntomas No\\NMotores Tard√≠os:",
            "children": [
              {
                "text": "1. Trastornos axiales\\Nresistentes a tratamiento:",
                "children": [
                  {
                    "text": "‚Ä¢ Aparecen 5-10 a√±os despu√©s del inicio.",
                    "children": []
                  }
                ]
              },
              {
                "text": "2. Freezing/inestabilidad\\Npostural/ca√≠das:",
                "children": [
                  {
                    "text": "‚Ä¢ Frecuencia: ~50% a los 15 a√±os.",
                    "children": []
                  }
                ]
              },
              {
                "text": "3. Disfagia:",
                "children": [
                  {
                    "text": "‚Ä¢ Frecuencia: 50% a los 15 a√±os.",
                    "children": []
                  }
                ]
              },
              {
                "text": "4. Psicosis:",
                "children": [
                  {
                    "text": "‚Ä¢ Frecuencia: ~55%.",
                    "children": []
                  }
                ]
              },
              {
                "text": "5. Disfunci√≥n auton√≥mica\\N(hipotensi√≥n ortost√°tica, nocturia):",
                "children": [
                  {
                    "text": "‚Ä¢ Frecuencia variable (15-30%).",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "Deterioro\\NCognitivo:",
            "children": [
              {
                "text": "1. Deterioro cognitivo leve:",
                "children": [
                  {
                    "text": "‚Ä¢ Frecuencia: 35% al diagn√≥stico, aumenta con la duraci√≥n de la enfermedad.",
                    "children": []
                  }
                ]
              },
              {
                "text": "2. Demencia:",
                "children": [
                  {
                    "text": "‚Ä¢ Frecuencia: >80% a los 20 a√±os del diagn√≥stico.",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "HISTORIA NATURAL",
        "children": [
          {
            "text": "1. Per√≠odo Pre-motor/Prodr√≥mico\\N(hasta 20 a√±os antes del diagn√≥stico):",
            "children": [
              {
                "text": "‚Ä¢ S√≠ntomas tempranos\\Nno motores:",
                "children": [
                  {
                    "text": "‚Ä¢ Constipaci√≥n.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Trastornos del sue√±o REM (RBD).",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Hiposmia.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Depresi√≥n.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Somnolencia diurna excesiva (EDS).",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Cambios sutiles que preceden los s√≠ntomas motores.",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "2. Inicio del Parkinson\\N(Diagn√≥stico):",
            "children": [
              {
                "text": "‚Ä¢ Fase\\Ntemprana:",
                "children": [
                  {
                    "text": "‚Ä¢ S√≠ntomas motores iniciales:",
                    "children": [
                      {
                        "text": "‚Ä¢ Bradicinesia, rigidez, temblor.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ S√≠ntomas no motores asociados:",
                    "children": [
                      {
                        "text": "‚Ä¢ Fatiga, dolor, deterioro cognitivo leve (MCI).",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "3. Fase\\NAvanzada:",
            "children": [
              {
                "text": "‚Ä¢ Complicaciones\\Nmotoras:",
                "children": [
                  {
                    "text": "‚Ä¢ Fluctuaciones motoras (on/off).",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Disquinesias inducidas por levodopa.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Inestabilidad postural, freezing de la marcha, ca√≠das.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Complicaciones\\Nno motoras:",
                "children": [
                  {
                    "text": "‚Ä¢ Disfagia, hipotensi√≥n ortost√°tica, s√≠ntomas urinarios.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Demencia asociada al Parkinson.",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "4. Etapa\\NTard√≠a:",
            "children": [
              {
                "text": "‚Ä¢ Discapacidad significativa.",
                "children": []
              },
              {
                "text": "‚Ä¢ Psicosis, alucinaciones.",
                "children": []
              },
              {
                "text": "‚Ä¢ Muerte secundaria a complicaciones (p. ej., infecciones).",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "PROGRESION DE\\NLA ENFERMEDAD",
        "children": [
          {
            "text": "PROGRESI√ìN ANATOMOPATOL√ìGICA\\N(BRAAK)",
            "children": [
              {
                "text": "- Etapa 1-2\\N(Prodr√≥mico)",
                "children": [
                  {
                    "text": "-- Bulbo olfatorio/N√∫cleo dorsal vago",
                    "children": []
                  },
                  {
                    "text": "-- Correlaci√≥n: anosmia/constipaci√≥n",
                    "children": []
                  },
                  {
                    "text": "-- Duraci√≥n: 5-20 a√±os prediagn√≥stico",
                    "children": []
                  },
                  {
                    "text": "-- S√≠ntomas auton√≥micos precoces",
                    "children": []
                  }
                ]
              },
              {
                "text": "- Etapa 3-4\\N(Diagn√≥stico)",
                "children": [
                  {
                    "text": "-- Afectaci√≥n SNpc/Mesenc√©falo",
                    "children": []
                  },
                  {
                    "text": "-- Inicio s√≠ntomas motores (>60% p√©rdida)",
                    "children": []
                  },
                  {
                    "text": "-- Asimetr√≠a caracter√≠stica",
                    "children": []
                  },
                  {
                    "text": "-- RBD marcador temprano",
                    "children": []
                  }
                ]
              },
              {
                "text": "- Etapa 5-6\\N(Avanzado)",
                "children": [
                  {
                    "text": "-- Extensi√≥n neocortical",
                    "children": []
                  },
                  {
                    "text": "-- Deterioro cognitivo progresivo",
                    "children": []
                  },
                  {
                    "text": "-- Psicosis/trastornos conducta",
                    "children": []
                  },
                  {
                    "text": "-- Dependencia funcional",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "PROGRESION CL√çNICA\\NEscala de Hoenh y Yarh",
            "children": [
              {
                "text": "Estadio 0:",
                "children": [
                  {
                    "text": "‚Ä¢ No hay signos de enfermedad.",
                    "children": []
                  }
                ]
              },
              {
                "text": "Estadio 1:",
                "children": [
                  {
                    "text": "‚Ä¢ Afectaci√≥n unilateral.",
                    "children": []
                  }
                ]
              },
              {
                "text": "Estadio 2:",
                "children": [
                  {
                    "text": "‚Ä¢ Enfermedad bilateral, pero sin alteraci√≥n del equilibrio.",
                    "children": []
                  }
                ]
              },
              {
                "text": "Estadio 3:",
                "children": [
                  {
                    "text": "‚Ä¢ Enfermedad\\Nbilateral moderada:",
                    "children": [
                      {
                        "text": "‚Ä¢ Inestabilidad postural.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Paciente permanece f√≠sicamente independiente.",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "Estadio 4:",
                "children": [
                  {
                    "text": "‚Ä¢ Incapacidad grave:",
                    "children": [
                      {
                        "text": "‚Ä¢ Puede caminar o permanecer de pie, pero requiere asistencia.",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "Estadio 5:",
                "children": [
                  {
                    "text": "‚Ä¢ Dependencia completa:",
                    "children": [
                      {
                        "text": "‚Ä¢ El paciente permanece en silla de ruedas o encamado sin ayuda.",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "ESTUDIO",
        "children": [
          {
            "text": "1. Resonancia Magn√©tica Nuclear\\N(RMN):",
            "children": [
              {
                "text": "‚Ä¢ Principalmente para excluir otras causas de parkinsonismo secundario\\N(lesiones estructurales, vasculares o tumorales).",
                "children": []
              }
            ]
          },
          {
            "text": "2. DaTscan (SPECT dopamin√©rgico):",
            "children": [
              {
                "text": "‚Ä¢ Visualiza la funci√≥n dopamin√©rgica presin√°ptica.",
                "children": []
              },
              {
                "text": "‚Ä¢ Ayuda a diferenciar Parkinson idiop√°tico de parkinsonismo at√≠pico o inducido por f√°rmacos.",
                "children": []
              }
            ]
          },
          {
            "text": "3. PET (Tomograf√≠a por\\NEmisi√≥n de Positrones):",
            "children": [
              {
                "text": "‚Ä¢ Eval√∫a actividad metab√≥lica y funcional cerebral.",
                "children": []
              },
              {
                "text": "‚Ä¢ Menos accesible, pero √∫til en investigaci√≥n o casos complejos.",
                "children": []
              }
            ]
          },
          {
            "text": "4. Test de olfato:",
            "children": [
              {
                "text": "‚Ä¢ P√©rdida de olfato (hiposmia) es un marcador temprano y frecuente en Parkinson.",
                "children": []
              }
            ]
          },
          {
            "text": "5. Ecograf√≠a\\Ntranscraneana:",
            "children": [
              {
                "text": "‚Ä¢ Eval√∫a ecogenicidad de ganglios basales (sustancia negra).",
                "children": []
              },
              {
                "text": "‚Ä¢ Operador-dependiente; √∫til en centros especializados.",
                "children": []
              }
            ]
          },
          {
            "text": "6. Cintigraf√≠a mioc√°rdica\\N(MIBG):",
            "children": [
              {
                "text": "‚Ä¢ Eval√∫a denervaci√≥n simp√°tica card√≠aca.",
                "children": []
              },
              {
                "text": "‚Ä¢ Puede distinguir Parkinson idiop√°tico de parkinsonismos at√≠picos.",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "Diagn√≥stico Diferencial\\Nen Parkinsonismo",
        "children": [
          {
            "text": "1. Enfermedad de Parkinson (Idiop√°tica):",
            "children": [
              {
                "text": "‚Ä¢ Forma espor√°dica o gen√©tica.",
                "children": []
              }
            ]
          },
          {
            "text": "2. Parkinsonismo\\NSecundario:",
            "children": [
              {
                "text": "‚Ä¢ Inducido por f√°rmacos:",
                "children": [
                  {
                    "text": "‚Ä¢ Antipsic√≥ticos, antiem√©ticos, bloqueadores de dopamina.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Vascular:",
                "children": [
                  {
                    "text": "‚Ä¢ Infartos lacunares en ganglios basales.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ T√≥xico:",
                "children": [
                  {
                    "text": "‚Ä¢ Exposici√≥n a manganeso, mon√≥xido de carbono.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Infeccioso:",
                "children": [
                  {
                    "text": "‚Ä¢ VIH, neuros√≠filis, encefalitis postviral.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Normal Pressure Hydrocephalus (NPH):",
                "children": [
                  {
                    "text": "‚Ä¢ Parkinsonismo, demencia, incontinencia urinaria.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Neopl√°sico:",
                "children": [
                  {
                    "text": "‚Ä¢ Tumores en regi√≥n basal del cerebro.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Trauma:",
                "children": [
                  {
                    "text": "‚Ä¢ Parkinsonismo postraum√°tico.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Falla hep√°tica:",
                "children": [
                  {
                    "text": "‚Ä¢ Encefalopat√≠a metab√≥lica.",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "3. Parkinsonismos\\NAt√≠picos:",
            "children": [
              {
                "text": "‚Ä¢ Atrofia multisist√©mica (AMS):",
                "children": [
                  {
                    "text": "‚Ä¢ Disautonom√≠a prominente.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Par√°lisis supranuclear progresiva (PSP):",
                "children": [
                  {
                    "text": "‚Ä¢ Oftalmoplej√≠a vertical, rigidez axial.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ S√≠ndrome corticobasal:",
                "children": [
                  {
                    "text": "‚Ä¢ Apraxia, diston√≠a asim√©trica, mioclon√≠as.",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "4. Enfermedades\\NNeurodegenerativas:",
            "children": [
              {
                "text": "‚Ä¢ Demencia con\\Ncuerpos de Lewy:",
                "children": [
                  {
                    "text": "‚Ä¢ Parkinsonismo con alucinaciones y deterioro cognitivo temprano.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Enfermedad de Alzheimer con parkinsonismo.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Demencia\\Nfrontotemporal:",
                "children": [
                  {
                    "text": "‚Ä¢ Cambios conductuales, afasia.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Enfermedad por priones.",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "5. Otras\\NEnfermedades:",
            "children": [
              {
                "text": "‚Ä¢ Enfermedad de Wilson:",
                "children": [
                  {
                    "text": "‚Ä¢ Alteraci√≥n del metabolismo del cobre.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Huntington:",
                "children": [
                  {
                    "text": "‚Ä¢ Movimientos coreicos, trastornos psiqui√°tricos.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ S√≠ndrome de Kufor-Rakeb:",
                "children": [
                  {
                    "text": "‚Ä¢ Parkinsonismo juvenil con alteraciones oculomotoras.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Diston√≠a sensible a dopamina (DRD).",
                "children": []
              },
              {
                "text": "‚Ä¢ Neurodegeneraci√≥n con acumulaci√≥n de hierro en el cerebro (NBIA).",
                "children": []
              },
              {
                "text": "‚Ä¢ Ataxia-tremor-parkinsonismo asociado al s√≠ndrome X fr√°gil.",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "Tratamiento",
        "children": [
          {
            "text": "Sintomas\\Nmotores",
            "children": [
              {
                "text": "Levodopa\\N(Gold Standard):",
                "children": [
                  {
                    "text": "‚Ä¢ Combinaci√≥n:",
                    "children": [
                      {
                        "text": "‚Ä¢ Levodopa + Carbidopa o Benserazida (inhibidores de descarboxilasa perif√©rica).",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Uso:",
                    "children": [
                      {
                        "text": "‚Ä¢ Monoterapia en etapas iniciales (particularmente en mayores).",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Adjunta a otros tratamientos en etapas avanzadas.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Efectos secundarios:",
                    "children": [
                      {
                        "text": "‚Ä¢ Fluctuaciones motoras (‚Äúon/off‚Äù), disquinesias a largo plazo.",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "Agonistas\\NDopamin√©rgicos:",
                "children": [
                  {
                    "text": "‚Ä¢ No Ergot\\N(preferidos):",
                    "children": [
                      {
                        "text": "‚Ä¢ Apomorfina, Pramipexol, Ropinirol, Rotigotina.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Uso en j√≥venes para retrasar el inicio de levodopa.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Ergot (menos\\Nusados):",
                    "children": [
                      {
                        "text": "‚Ä¢ Bromocriptina, Cabergolina.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Mayor riesgo de fibrosis valvular y retroperitoneal.",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "Inhibidores\\Nde MAO-B:",
                "children": [
                  {
                    "text": "‚Ä¢ F√°rmacos:",
                    "children": [
                      {
                        "text": "‚Ä¢ Rasagilina, Selegilina.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Efecto:",
                    "children": [
                      {
                        "text": "‚Ä¢ Incrementan la disponibilidad de dopamina en el SNC.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Indicaci√≥n:",
                    "children": [
                      {
                        "text": "‚Ä¢ Monoterapia o combinaci√≥n con levodopa para retrasar complicaciones.",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "Inhibidores de la Catecol-O-Metiltransferasa\\N(ICOMT):",
                "children": [
                  {
                    "text": "‚Ä¢ F√°rmacos:",
                    "children": [
                      {
                        "text": "‚Ä¢ Entacapona, Tolcapona.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Efecto:",
                    "children": [
                      {
                        "text": "‚Ä¢ Prolongan la acci√≥n de levodopa.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Indicaci√≥n:",
                    "children": [
                      {
                        "text": "‚Ä¢ Uso combinado en etapas con fluctuaciones motoras.",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "Otros\\NTratamientos:",
                "children": [
                  {
                    "text": "‚Ä¢ Amantadina:",
                    "children": [
                      {
                        "text": "‚Ä¢ √ötil en disquinesias inducidas por levodopa.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Anticolin√©rgicos\\N(Trihexifenidilo, Biperideno):",
                    "children": [
                      {
                        "text": "‚Ä¢ Para temblor predominante en pacientes j√≥venes.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Uso limitado por efectos secundarios cognitivos.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Clozapina:",
                    "children": [
                      {
                        "text": "‚Ä¢ Manejo de psicosis resistente.",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "S√≠ntomas\\NNo Motores",
            "children": [
              {
                "text": "N√°usea:",
                "children": [
                  {
                    "text": "‚Ä¢ F√°rmaco: Domperidona.",
                    "children": [
                      {
                        "text": "‚Ä¢ Dosis: 10 mg tres veces al d√≠a, hasta 20 mg cuatro veces al d√≠a.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Efectos adversos:",
                    "children": [
                      {
                        "text": "‚Ä¢ Arritmias card√≠acas, muerte s√∫bita, dolor tor√°cico, sofocos.",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "Trastornos del\\Nsue√±o REM (RBD):",
                "children": [
                  {
                    "text": "‚Ä¢ F√°rmacos:",
                    "children": [
                      {
                        "text": "‚Ä¢ Clonazepam: 0.25-2 mg a la hora de dormir.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Melatonina: 3-15 mg a la hora de dormir.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Efectos\\Nadversos:",
                    "children": [
                      {
                        "text": "‚Ä¢ Clonazepam: Sedaci√≥n, confusi√≥n.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Melatonina: Somnolencia diurna, mareos, cefalea.",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "Depresi√≥n:",
                "children": [
                  {
                    "text": "‚Ä¢ F√°rmacos\\NISRS:",
                    "children": [
                      {
                        "text": "‚Ä¢ Fluoxetina: 10-50 mg una vez al d√≠a.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Paroxetina: 10-40 mg una vez al d√≠a.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Sertralina: 50-200 mg una vez al d√≠a.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ F√°rmacos IRSN:",
                    "children": [
                      {
                        "text": "‚Ä¢ Venlafaxina: 37. 5-210 mg al d√≠a.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Antidepresivos\\Ntric√≠clicos:",
                    "children": [
                      {
                        "text": "‚Ä¢ Nortriptilina: 25-75 mg divididos en dosis.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Desipramina: 10-150 mg al d√≠a.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Efectos\\Nadversos:",
                    "children": [
                      {
                        "text": "‚Ä¢ ISRS/IRSN: Insomnio, disfunci√≥n sexual, n√°useas.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Tric√≠clicos: Riesgo de efectos anticolin√©rgicos, ortostatismo, sedaci√≥n.",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "Alucinaciones/Psicosis:",
                "children": [
                  {
                    "text": "‚Ä¢ F√°rmacos\\Nantipsic√≥ticos at√≠picos:",
                    "children": [
                      {
                        "text": "‚Ä¢ Clozapina: 6.25-150 mg/d√≠a en dosis divididas.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Quetiapina: 25-300 mg/d√≠a a la hora de dormir.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Inhibidores de colinesterasa:",
                    "children": [
                      {
                        "text": "‚Ä¢ Rivastigmina: 4.5-9.8 mg/24 h (parches transd√©rmicos).",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Efectos\\Nadversos:",
                    "children": [
                      {
                        "text": "‚Ä¢ Clozapina: Agranulocitosis, sedaci√≥n, miocarditis.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Quetiapina: S√≠ntomas extrapiramidales, sedaci√≥n.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Rivastigmina: N√°useas, bradicardia, temblores.",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "Disfunci√≥n\\NCognitiva\\N(PDD):",
                "children": [
                  {
                    "text": "‚Ä¢ F√°rmacos inhibidores\\Nde colinesterasa:",
                    "children": [
                      {
                        "text": "‚Ä¢ Donepezilo: 5-10 mg una vez al d√≠a.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Galantamina: 4-12 mg dos veces al d√≠a.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Rivastigmina: 4.5-9.8 mg/24 h (parche transd√©rmico).",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Efectos adversos:",
                    "children": [
                      {
                        "text": "‚Ä¢ N√°useas, v√≥mitos, diarrea, bradicardia.",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "Hipotensi√≥n\\NOrtost√°tica:",
                "children": [
                  {
                    "text": "‚Ä¢ F√°rmacos:",
                    "children": [
                      {
                        "text": "‚Ä¢ Fludrocortisona: 0.05-0.1 mg una vez o dos veces al d√≠a.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Midodrina: 2.5-10 mg tres veces al d√≠a.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Domperidona: 10 mg tres veces al d√≠a (m√°ximo 20 mg cuatro veces al d√≠a).",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Piridostigmina: 50 mg tres veces al d√≠a.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Indometacina: 50 mg tres veces al d√≠a.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Droxidopa: 300 mg tres veces al d√≠a.",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Yohimbina: 2 mg tres veces al d√≠a.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Efectos adversos:",
                    "children": [
                      {
                        "text": "‚Ä¢ Hipertensi√≥n, n√°useas, retenci√≥n urinaria, alteraciones cardiovasculares.",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "Sialorrea:",
                "children": [
                  {
                    "text": "‚Ä¢ F√°rmacos:",
                    "children": [
                      {
                        "text": "‚Ä¢ Atropina (1-2 gotas de soluci√≥n 1% sublingual hasta cuatro veces al d√≠a).",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Bromuro de ipratropio (spray 0.03%, 2 sprays hasta 4 veces al d√≠a).",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Inyecciones de toxina botul√≠nica tipo A (BTA) y tipo B (BTB):",
                        "children": [
                          {
                            "text": "‚Ä¢ Dosis variable seg√∫n la formulaci√≥n.",
                            "children": []
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Efectos adversos:",
                    "children": [
                      {
                        "text": "‚Ä¢ Xerostom√≠a, molestias asociadas a la inyecci√≥n, visi√≥n borrosa.",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "No Farmacol√≥gico",
            "children": [
              {
                "text": "Kinesioterapia:",
                "children": [
                  {
                    "text": "‚Ä¢ Mejora movilidad, equilibrio y prevenci√≥n de ca√≠das.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Programas espec√≠ficos para la marcha y postura.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Ejercicios que favorecen la amplitud de movimientos y flexibilidad.",
                    "children": []
                  }
                ]
              },
              {
                "text": "Fonoaudiolog√≠a",
                "children": [
                  {
                    "text": "- LSVT-LOUD¬Æ",
                    "children": []
                  },
                  {
                    "text": "- Manejo disfagia",
                    "children": []
                  },
                  {
                    "text": "- Comunicaci√≥n",
                    "children": []
                  }
                ]
              },
              {
                "text": "Terapia\\NOcupacional:",
                "children": [
                  {
                    "text": "‚Ä¢ Adaptaci√≥n del entorno para facilitar actividades de la vida diaria.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Entrenamiento en el uso de dispositivos de asistencia.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Mejora en la funcionalidad manual y motora.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Estimulaci√≥n\\Ncognitiva",
                    "children": [
                      {
                        "text": "- Ejercicios atenci√≥n",
                        "children": []
                      },
                      {
                        "text": "- Planificaci√≥n/secuenciaci√≥n",
                        "children": []
                      },
                      {
                        "text": "- Compensaci√≥n d√©ficits",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "Tratamiento Quir√∫rgico\\N(DBS - Deep Brain Stimulation):",
                "children": [
                  {
                    "text": "‚Ä¢ Indicaciones:",
                    "children": [
                      {
                        "text": "‚Ä¢ Pacientes con complicaciones motoras refractarias al tratamiento farmacol√≥gico.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Procedimiento:",
                    "children": [
                      {
                        "text": "‚Ä¢ Estimulaci√≥n cerebral profunda dirigida al n√∫cleo subtal√°mico o t√°lamo.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Beneficios:",
                    "children": [
                      {
                        "text": "‚Ä¢ Reducci√≥n de fluctuaciones motoras y disquinesias.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Limitaciones:",
                    "children": [
                      {
                        "text": "‚Ä¢ No modifica la progresi√≥n de la enfermedad.",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "MANEJO",
        "children": [
          {
            "text": "TERAPIA\\NFARMACOL√ìGICA INICIAL",
            "children": [
              {
                "text": "L-DOPA\\N(primera l√≠nea >70a)",
                "children": [
                  {
                    "text": "1. Inicio",
                    "children": [
                      {
                        "text": "- 1/4 comp (50/125mg) c/8h",
                        "children": []
                      },
                      {
                        "text": "- Con alimentos (no prote√≠nas)",
                        "children": []
                      },
                      {
                        "text": "- Titulaci√≥n 3-4 semanas",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "2. Ajuste",
                    "children": [
                      {
                        "text": "- Incrementos 25%",
                        "children": []
                      },
                      {
                        "text": "- Meta: funcionalidad/EA",
                        "children": []
                      },
                      {
                        "text": "- Monitorizaci√≥n respuesta",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "3. Formulaciones",
                    "children": [
                      {
                        "text": "- Est√°ndar: +carbidopa",
                        "children": []
                      },
                      {
                        "text": "- Dispersable: disfagia",
                        "children": []
                      },
                      {
                        "text": "- Liberaci√≥n controlada: noche",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "Agonistas Dopamin√©rgicos\\N(<65a)",
                "children": [
                  {
                    "text": "1. Pramipexol",
                    "children": [
                      {
                        "text": "- Inicio: 0.125mg c/8h",
                        "children": []
                      },
                      {
                        "text": "- Titular gradualmente",
                        "children": []
                      },
                      {
                        "text": "- Vigilar impulsos/psicosis",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "2. Rotigotina\\N(parche)",
                    "children": [
                      {
                        "text": "- Inicio: 2mg/24h",
                        "children": []
                      },
                      {
                        "text": "- M√°ximo: 8mg/24h",
                        "children": []
                      },
                      {
                        "text": "- √ötil disfagia/cirug√≠a",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "MANEJO S√çNTOMAS\\NNO MOTORES",
            "children": [
              {
                "text": "A. Trastornos\\Nsue√±o",
                "children": [
                  {
                    "text": "1. RBD",
                    "children": [
                      {
                        "text": "- Melatonina 3-15mg noche",
                        "children": []
                      },
                      {
                        "text": "- Clonazepam 0.5-2mg",
                        "children": []
                      },
                      {
                        "text": "- Medidas ambientales",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "2. Insomnio",
                    "children": [
                      {
                        "text": "- Higiene sue√±o",
                        "children": []
                      },
                      {
                        "text": "- Trazodona/mirtazapina",
                        "children": []
                      },
                      {
                        "text": "- Ajuste medicaci√≥n EP",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "B. Neuropsiqui√°tricos",
                "children": [
                  {
                    "text": "1. Depresi√≥n",
                    "children": [
                      {
                        "text": "- ISRS: sertralina/escitalopram",
                        "children": []
                      },
                      {
                        "text": "- IRSN: venlafaxina/duloxetina",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "2. Psicosis",
                    "children": [
                      {
                        "text": "- Quetiapina 12.5-50mg",
                        "children": []
                      },
                      {
                        "text": "- Clozapina (casos selectos)",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "Algoritmo para el Tratamiento de\\Nlos S√≠ntomas Motores",
        "children": [
          {
            "text": "1. Diagn√≥stico Inicial:",
            "children": [
              {
                "text": "‚Ä¢ Confirmado:",
                "children": [
                  {
                    "text": "‚Ä¢ Determinar si hay afectaci√≥n motora.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Incierto:",
                "children": [
                  {
                    "text": "‚Ä¢ Solicitar RMN, DaTScan o im√°genes VMAT para descartar diagn√≥sticos alternativos.",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "2. Estrategia seg√∫n\\Nla severidad:",
            "children": [
              {
                "text": "‚Ä¢ S√≠ntomas m√≠nimos o ausentes:",
                "children": [
                  {
                    "text": "‚Ä¢ Terapia no farmacol√≥gica (ejercicio).",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Considerar IMAO-B (selegilina, rasagilina).",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ S√≠ntomas leves:",
                "children": [
                  {
                    "text": "‚Ä¢ Pacientes j√≥venes:",
                    "children": [
                      {
                        "text": "‚Ä¢ Agregar anticolin√©rgicos o toxina botul√≠nica (BoNT) para temblor y diston√≠a.",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Pacientes mayores:",
                    "children": [
                      {
                        "text": "‚Ä¢ Iniciar tratamiento con levodopa.",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "‚Ä¢ S√≠ntomas molestos:",
                "children": [
                  {
                    "text": "‚Ä¢ Iniciar levodopa como primera l√≠nea.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Alternativas: agonistas dopamin√©rgicos (pramipexol, ropinirol), amantadina, apomorfina.",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "3. Progresi√≥n de la\\NEnfermedad:",
            "children": [
              {
                "text": "‚Ä¢ Ajustes farmacol√≥gicos:",
                "children": [
                  {
                    "text": "‚Ä¢ Incrementar la dosis de levodopa o combinar con ICOMT (entacapona, tolcapona).",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Ajustes adicionales para manejar complicaciones motoras (fluctuaciones, disquinesias).",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Tratamientos\\Navanzados:",
                "children": [
                  {
                    "text": "‚Ä¢ Considerar estimulaci√≥n cerebral profunda (DBS) o\\Nultrasonido focalizado (FUS) para casos refractarios.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Terapias experimentales en investigaci√≥n.",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "Predictores\\Nevoluci√≥n",
        "children": [
          {
            "text": "1. Cl√≠nicos\\Nprincipales",
            "children": [
              {
                "text": "- Edad inicio",
                "children": []
              },
              {
                "text": "- Fenotipo inicial",
                "children": []
              },
              {
                "text": "- Respuesta L-DOPA",
                "children": []
              },
              {
                "text": "- Deterioro cognitivo precoz",
                "children": []
              }
            ]
          },
          {
            "text": "2. Biomarcadores\\Nvalidados",
            "children": [
              {
                "text": "- Severidad s√≠ntomas no motores",
                "children": []
              },
              {
                "text": "- RBD establecido",
                "children": []
              },
              {
                "text": "- Progresi√≥n imagenol√≥gica",
                "children": []
              },
              {
                "text": "- Denervaci√≥n auton√≥mica",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "Pron√≥stico",
        "children": [
          {
            "text": "1. Caracter√≠sticas\\NGenerales:",
            "children": [
              {
                "text": "‚Ä¢ Enfermedad progresiva:",
                "children": [
                  {
                    "text": "‚Ä¢ Agravamiento de la sintomatolog√≠a motora y no motora con el tiempo.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Efectos adversos secundarios a los f√°rmacos (RAM).",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "2. Mortalidad:",
            "children": [
              {
                "text": "‚Ä¢ Mayor mortalidad general\\Npor todas las causas:",
                "children": [
                  {
                    "text": "- Neumon√≠a aspirativa",
                    "children": []
                  },
                  {
                    "text": "- Complicaciones ca√≠das",
                    "children": []
                  },
                  {
                    "text": "- Infecciones urinarias",
                    "children": []
                  },
                  {
                    "text": "- Eventos cardiovasculares",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Tasas de mortalidad\\Ny discapacidad:",
                "children": [
                  {
                    "text": "‚Ä¢ 25% mortalidad o discapacidad severa a los 5 a√±os.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ 67% mortalidad a los 5-9 a√±os.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ 80% mortalidad a los 10-14 a√±os.",
                    "children": []
                  },
                  {
                    "text": "- EMV reducida 5-10 a√±os",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "3. Impacto\\NFuncional:",
            "children": [
              {
                "text": "‚Ä¢ Mayor institucionalizaci√≥n:",
                "children": [
                  {
                    "text": "‚Ä¢ Dependencia funcional progresiva.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Discapacidad severa:",
                "children": [
                  {
                    "text": "‚Ä¢ Pacientes postrados o con dependencia total en las etapas tard√≠as.",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "4. Deterioro\\NCognitivo:",
            "children": [
              {
                "text": "‚Ä¢ Progresi√≥n\\Na demencia:",
                "children": [
                  {
                    "text": "‚Ä¢ 60% de los pacientes a los 12 a√±os.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ 80% a los 14 a√±os.",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "CUIDADOS PALIATIVOS\\NY ETAPA AVANZADA",
        "children": [
          {
            "text": "8.1 DEFINICI√ìN\\NETAPA AVANZADA",
            "children": [
              {
                "text": "A. Criterios\\Ncl√≠nicos mayores",
                "children": [
                  {
                    "text": "1. Motores",
                    "children": [
                      {
                        "text": "- Dependencia silla ruedas/cama",
                        "children": []
                      },
                      {
                        "text": "- Disfagia severa",
                        "children": []
                      },
                      {
                        "text": "- Ca√≠das frecuentes",
                        "children": []
                      },
                      {
                        "text": "- Fluctuaciones incapacitantes",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "2. No motores",
                    "children": [
                      {
                        "text": "- Demencia establecida",
                        "children": []
                      },
                      {
                        "text": "- Psicosis recurrente",
                        "children": []
                      },
                      {
                        "text": "- Disautonom√≠a severa",
                        "children": []
                      },
                      {
                        "text": "- Trastornos conducta graves",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "B. Indicadores\\Npron√≥sticos",
                "children": [
                  {
                    "text": "1. Escala\\Nfuncional",
                    "children": [
                      {
                        "text": "- H&Y estadio 4-5",
                        "children": []
                      },
                      {
                        "text": "- Barthel <50 puntos",
                        "children": []
                      },
                      {
                        "text": "- FAQ >15 puntos",
                        "children": []
                      },
                      {
                        "text": "- Dependencia total cuidados",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "2. Complicaciones\\Nestablecidas",
                    "children": [
                      {
                        "text": "- Neumon√≠a aspirativa recurrente",
                        "children": []
                      },
                      {
                        "text": "- Fracturas patol√≥gicas",
                        "children": []
                      },
                      {
                        "text": "- √ölceras por presi√≥n",
                        "children": []
                      },
                      {
                        "text": "- Infecciones recurrentes",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "8.2 MANEJO PALIATIVO\\NESPEC√çFICO",
            "children": [
              {
                "text": "A. Objetivos\\Nterap√©uticos",
                "children": [
                  {
                    "text": "1. Prioridades",
                    "children": [
                      {
                        "text": "- Control s√≠ntomas",
                        "children": []
                      },
                      {
                        "text": "- Calidad vida",
                        "children": []
                      },
                      {
                        "text": "- Confort",
                        "children": []
                      },
                      {
                        "text": "- Apoyo familia",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "2. Decisiones\\Nterap√©uticas",
                    "children": [
                      {
                        "text": "- Simplificaci√≥n farmacol√≥gica",
                        "children": []
                      },
                      {
                        "text": "- Nutrici√≥n adaptada",
                        "children": []
                      },
                      {
                        "text": "- Suspensi√≥n f√∫til",
                        "children": []
                      },
                      {
                        "text": "- Preferencias paciente",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "B. Red asistencial\\Npaliativa",
                "children": [
                  {
                    "text": "1. Chile\\Np√∫blico",
                    "children": [
                      {
                        "text": "- Programa alivio dolor",
                        "children": []
                      },
                      {
                        "text": "- Atenci√≥n domiciliaria",
                        "children": []
                      },
                      {
                        "text": "- Hospitalizaciones abreviadas",
                        "children": []
                      },
                      {
                        "text": "- Red apoyo comunal",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "2. Niveles\\Natenci√≥n",
                    "children": [
                      {
                        "text": "- APS: seguimiento base",
                        "children": []
                      },
                      {
                        "text": "- Hospital: descompensaciones",
                        "children": []
                      },
                      {
                        "text": "- Domicilio: control s√≠ntomas",
                        "children": []
                      },
                      {
                        "text": "- Instituciones: cuidados cr√≥nicos",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "Demencia Asociada a la\\NEnfermedad de Parkinson (DAP)",
        "children": [
          {
            "text": "1. Caracter√≠sticas:",
            "children": [
              {
                "text": "‚Ä¢ Tiempo de aparici√≥n:",
                "children": [
                  {
                    "text": "‚Ä¢ Ocurre m√°s de 1 a√±o despu√©s del inicio de los s√≠ntomas motores.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Similitudes:",
                "children": [
                  {
                    "text": "‚Ä¢ Cl√≠nica y anatom√≠a patol√≥gica similar a la demencia con cuerpos de Lewy (DCL).",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Aparici√≥n:",
                "children": [
                  {
                    "text": "‚Ä¢ Generalmente en etapas tard√≠as de la enfermedad.",
                    "children": []
                  }
                ]
              },
              {
                "text": "A. Perfil cognitivo",
                "children": [
                  {
                    "text": "1. Patr√≥n disejecutivo\\Npredominante",
                    "children": [
                      {
                        "text": "- Atenci√≥n fluctuante",
                        "children": []
                      },
                      {
                        "text": "- Velocidad procesamiento",
                        "children": []
                      },
                      {
                        "text": "- Memoria trabajo",
                        "children": []
                      },
                      {
                        "text": "- Planificaci√≥n alterada",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "2. Alteraciones\\Nvisuoespaciales",
                    "children": [
                      {
                        "text": "- Reconocimiento facial",
                        "children": []
                      },
                      {
                        "text": "- Orientaci√≥n espacial",
                        "children": []
                      },
                      {
                        "text": "- Percepci√≥n visual",
                        "children": []
                      },
                      {
                        "text": "- Praxias constructivas",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "3. Memoria",
                    "children": [
                      {
                        "text": "- D√©ficit recuperaci√≥n > almacenamiento",
                        "children": []
                      },
                      {
                        "text": "- Beneficio con claves",
                        "children": []
                      },
                      {
                        "text": "- Reconocimiento preservado inicial",
                        "children": []
                      },
                      {
                        "text": "- Autobiogr√°fica respetada",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "2. Terapia:",
            "children": [
              {
                "text": "‚Ä¢ Tratamiento:",
                "children": [
                  {
                    "text": "‚Ä¢ Similar al tratamiento de la DCL.",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Manejo de agitaci√≥n\\Ny delirium:",
                "children": [
                  {
                    "text": "‚Ä¢ Quetiapina: Antipsic√≥tico de elecci√≥n.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Benzodiazepinas: En casos espec√≠ficos y bajo control.",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "3. S√≠ntomas Psic√≥ticos\\NAsociados a F√°rmacos:",
            "children": [
              {
                "text": "‚Ä¢ Asociados a medicamentos utilizados\\Nen el tratamiento del Parkinson:",
                "children": [
                  {
                    "text": "‚Ä¢ Anticolin√©rgicos.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Agonistas dopamin√©rgicos.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ ICOMT (entacapona, tolcapona).",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Levodopa: Particularmente en formulaciones de liberaci√≥n prolongada (XR).",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Manejo:",
                "children": [
                  {
                    "text": "‚Ä¢ Ajustar dosis o retirar medicamentos si es necesario.",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      }
    ]
  },
  "related_maps": [
    {
      "id": "map_1688",
      "title": "CLARITY-AD (2022)\\NLecanemab in Early Alzheimers Disease\\N\\nLecanemab reduce deterioro cognitivo 27%\\nen EA temprana con amiloide confirmado\\nPrimer anti-amiloide con beneficio clinico claro"
    },
    {
      "id": "map_1689",
      "title": "SPRINTT (2021)\\NSarcopenia and Physical\\NFragility in Older People:\\NMulti-component Treatment\\N\\n‚≠ê Ejercicio + nutrici√≥n reduce\\ndiscapacidad en fragilidad f√≠sica\\ncon sarcopenia"
    },
    {
      "id": "map_1805",
      "title": "Deterioro Cognitivo Vascular (DCV)\\Ny Demencia Vascular"
    },
    {
      "id": "map_1107",
      "title": "Deterioro Cognitivo Vascular (DCV) y Demencia Vascular"
    },
    {
      "id": "map_1054",
      "title": "Evaluaci√≥n de la Demencia y el Deterioro Cognitivo  UTD 2025"
    }
  ],
  "source_file": "Enfermedad de Parkinson-2025.smmx",
  "created": "2026-02-07T15:43:05.461084"
}